StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
Huagongshe Open Project:[email protected]KI-Anbindung: llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.7.8
Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 1971Erstellt: 4. November 2026

4-(2-Amino-6-(cyclopropylamino)-9H-purin-9-yl)-2-cyclopentene-1-methanol

CS-107 · 1592u89 · Abacavir · Abacavir >Abacavir(base) · Abacavir Tablet · Abacavir, ≥ 98.0% · Abacavir USP/EP/BP · Abacavir Standard

https://huagongshe.com/de/chemical/1971

Molekülstruktur von 4-(2-Amino-6-(cyclopropylamino)-9H-purin-9-yl)-2-cyclopentene-1-methanol

Identifikatoren & physikalische Daten

CAS No.136470-78-5
SummenformelC14H18N6O
Durchschnittliche Molmasse286,33 g/mol
Monoisotopische Masse286,15420922 g/mol
SMILESNc1nc(NC2CC2)c2ncn(C3C=CC(CO)C3)c2n1
InChIKeyMCGSCOLBFJQGHM-UHFFFAOYSA-N
PubChem CID1971
DTXSIDDTXSID20861337

Chemische & physikalische Eigenschaften

XLogP0,9
Polarare Oberfläche (TPSA)102
H-Brücken-Donoren3
H-Brücken-Akzeptoren6
Frei drehbare Bindungen4
Schwere Atome21
Formalladung0
Komplexität414
ArzneimittelPharmaceuticals
Schmelzpunkt165°
Siedepunkt636.0±65.0 °C(Predicted)
Dichte1.70±0.1 g/cm3(Predicted)
LagerbedingungenSealed in dry,2-8°C
LöslichkeitDMSO (Slightly, Heated), Methanol (Slightly)
pKa (Säurekonstante)5.01(at 25℃)
AggregatzustandSolid
FarbeOff-White to Pale Beige
Merck14,1
BCS Class3
CAS Datenbank136470-78-5(CAS DataBase Reference)
EPA chemische Informationen2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S,4R)- (136470-78-5)

Sicherheit & Vorschriften

Zollcode2933.99.7500
RTECS-Nr.GY5979200

Anwendungen & Verwendung

Beschreibung

The drug is extensively metabolized via stepwise phosphorylation to 5′-mono-, di-, and triphosphate. Abacavir is well absorbed (>75%) and penetrates the CNS. The drug can be taken without regard to meals. The drug does not show any clinically significant drug–drug interactions. Abacavir has been reported to produce life-threatening hypersensitivity reactions. The major use of abacavir appears to be in combination with other nucleoside RT inhibitors. A fixed-combination product has recently been approved by the U.S. FDA consisting of 300 mg of ABC, 150 mg of 3TC, and 300 mg of ZDV (Trizivar). The combination has been shown to be superior to other combinations in reducing viral load as well as to show improvement in CD4 cell count.

Verwenden

Abacavir is a commonly used nucleoside analogue with potent antiviral activity against HIV-1. - See more at: http://www.selleckchem.com/products/abacavir-sulfate.html#sthash.lApvcTNO.dpuf